Bitmopost (allergen)
Collapse
X
-
Phase II is done by january-february.
they said they are having a presentation this month I believe, with final results in February. But the rumblings have all been positive.
If this thing works they'll be going straight to Phase III, finishing in february 2014, and launching it in market a few months later. This product is literally 2 years away barring a random setback.Leave a comment:
-
How do you know phase III begins in Feb??I'd say end of 2014 more likely, phase III begins in February, ends February 2014, a few months for production and you're talking probably august-october 2014 release.
If it has decent results it could tide a few people over until the 'major' products come out like the potentials Histogen, aderans etc.
Histogen aderans imo if they pass to phase III now, have no reason to wait until 2017-2018. If this stuff works now, and passes their current phases, we're looking at a 2015-2016 release. So it really depends on what happens in the next few months.
Phase II results are not out yet are they!Leave a comment:
-
Educated guess....June 2015 it will be on the shelf
This is by far the most realistic new treatment to come out in the next few years.
Treatments like Aderans, Histogen, Replicel will not realistically be available to the public until 2017-2018. This is just my opinion based on research of the companies and the FDA approval process.
I'd say end of 2014 more likely, phase III begins in February, ends February 2014, a few months for production and you're talking probably august-october 2014 release.
If it has decent results it could tide a few people over until the 'major' products come out like the potentials Histogen, aderans etc.
Histogen aderans imo if they pass to phase III now, have no reason to wait until 2017-2018. If this stuff works now, and passes their current phases, we're looking at a 2015-2016 release. So it really depends on what happens in the next few months.Leave a comment:
-
-
Dam it
I think it's a waste of time being on this site for another 3 yearsLeave a comment:
-
Educated guess....June 2015 it will be on the shelf
This is by far the most realistic new treatment to come out in the next few years.
Treatments like Aderans, Histogen, Replicel will not realistically be available to the public until 2017-2018. This is just my opinion based on research of the companies and the FDA approval process.Leave a comment:
-
as of right now I see it as a slightly better alternative to Minoxidil, which in itself is a great thing as some may see better results by being on allergan instead of Minoxidil and vice versa.
mots options is always great and to have an actual third product approved by the FDA is fantastic in itself.Leave a comment:
-
it will be great for those with up to a nw3-4. Mainly helpful for those who have diffuse thinning.Leave a comment:
-
Yeah defo be great for a maintain!
Will only be good for regrowth if used with a AALeave a comment:
-
-
It's is likely to be a super mixoxidiAgreed. There are centrifugal spinning devices which can separate BIM from its vehicle, leaving the raw compound to make a stronger version with, and yet we haven't heard of any success stories from anyone doing this, or from buying BIM by the gramme from China or wherever.
Spencer would have heard of such BIM successes, but he's predicting it won't amount to much, indicating he has heard no such success stories.
It's very good at increasing hair pigmentation! Minox can do this some what not not nearly as good as BIMLeave a comment:
-
Why do we
Why do we want to hear it if its not good news? Why we wasting our time here?Leave a comment:
-
Agreed. There are centrifugal spinning devices which can separate BIM from its vehicle, leaving the raw compound to make a stronger version with, and yet we haven't heard of any success stories from anyone doing this, or from buying BIM by the gramme from China or wherever.
Spencer would have heard of such BIM successes, but he's predicting it won't amount to much, indicating he has heard no such success stories.Leave a comment:

Leave a comment: